Literature DB >> 29848613

Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications.

Lydia D Hellwig1,2, Barbara B Biesecker3, Katie L Lewis4, Leslie G Biesecker4, Cynthia A James5, William M P Klein6.   

Abstract

BACKGROUND: Clinical genetic testing for heritable cardiovascular disease has become a widely used tool to aid in the management of patients and their families. A 5-category variant classification system is commonly used for genetic test results, but some laboratories further subclassify variants of uncertain significance. How and whether patients perceive differences among the variant categories or subclassifications of variants of uncertain significance is unknown.
METHODS: We tested whether participants perceived differences in genetic variant subclassifications on outcomes including risk comprehension, risk perception, worry, perceived uncertainty, and intentions. Order-randomized hypothetical cardiovascular genetic results were given to 289 participants enrolled in a genome sequencing study. Three categories of variants were presented to participants: variants of uncertain significance, possibly pathogenic, and likely pathogenic. Responses to the first variant presented were analyzed in a between-groups analysis, and responses to all 3 variants were analyzed in a within-groups analysis.
RESULTS: When presented with all 3 results, participants distinguished among the subclassifications on all outcomes (P<0.001). When given only a possibly pathogenic result, their risk perceptions were similar to those of variants of uncertain significance, but they were more worried and intended to behave as if they had received a likely pathogenic result. Individuals depended more on their affective responses such as worry when they received only one result (P<0.05).
CONCLUSIONS: Participants are better able to distinguish pathogenicity subclassifications when presented with multiple categories. Individuals who receive a single uncertain result in a cardiovascular disease gene may benefit from interventions to decrease worry, calibrate risk perceptions, and motivate variant-appropriate behaviors.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  classification; genetic testing; genetic variation; intention; uncertainty

Mesh:

Year:  2018        PMID: 29848613      PMCID: PMC5986092          DOI: 10.1161/CIRCGEN.117.001975

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN: 2574-8300


  19 in total

1.  Worry and risk perceptions as independent and interacting predictors of health protective behaviors.

Authors:  Rebecca A Ferrer; David B Portnoy; William M P Klein
Journal:  J Health Commun       Date:  2012-12-28

2.  PUGS: A novel scale to assess perceptions of uncertainties in genome sequencing.

Authors:  B B Biesecker; S W Woolford; W M P Klein; K B Brothers; K L Umstead; K L Lewis; L G Biesecker; P K J Han
Journal:  Clin Genet       Date:  2017-01-30       Impact factor: 4.438

3.  Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.

Authors:  Mary-Claire King; Ephrat Levy-Lahad; Amnon Lahad
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

4.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

5.  Risk perceptions and health behavior.

Authors:  Rebecca Ferrer; William M Klein
Journal:  Curr Opin Psychol       Date:  2015-10-01

6.  Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.

Authors:  Christine Maheu; Sally Thorne
Journal:  Res Nurs Health       Date:  2008-12       Impact factor: 2.228

7.  Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.

Authors:  Nancie Petrucelli; Noam Lazebnik; Karen M Huelsman; Roee S Lazebnik
Journal:  Genet Test       Date:  2002

8.  The challenge of comprehensive and consistent sequence variant interpretation between clinical laboratories.

Authors:  Melanie G Pepin; Mitzi L Murray; Samuel Bailey; Dru Leistritz-Kessler; Ulrike Schwarze; Peter H Byers
Journal:  Genet Med       Date:  2015-04-02       Impact factor: 8.822

9.  A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.

Authors:  Courtney L Scherr; Noralane M Lindor; Teri L Malo; Fergus J Couch; Susan T Vadaparampil
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

10.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

Authors:  Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins
Journal:  Genet Med       Date:  2016-08-17       Impact factor: 8.822

View more
  5 in total

1.  Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

Authors:  Ana Morales; Ray E Hershberger
Journal:  Circ Genom Precis Med       Date:  2018-06

2.  Perceptions of uncertainties about carrier results identified by exome sequencing in a randomized controlled trial.

Authors:  Kendall L Umstead; Paul K J Han; Katie L Lewis; Ilana M Miller; Charlotte L Hepler; Lydia J Thompson; Tyra G Wolfsberg; Anh-Dao Nguyen; Mark T Fredriksen; Gretchen Gibney; Erin Turbitt; Leslie G Biesecker; Barbara B Biesecker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

3.  Changes in genetic variant results over time in pediatric cardiomyopathy and electrophysiology.

Authors:  Sara Cherny; Rachael Olson; Kathryn Chiodo; Lauren C Balmert; Gregory Webster
Journal:  J Genet Couns       Date:  2020-07-24       Impact factor: 2.537

Review 4.  Informed Consent in the Genomics Era.

Authors:  Shannon Rego; Megan E Grove; Mildred K Cho; Kelly E Ormond
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

5.  Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice.

Authors:  I Christiaans; O R F Mook; M Alders; H Bikker; R H Lekanne Dit Deprez
Journal:  Neth Heart J       Date:  2019-06       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.